HomeAI · summaries
Storia in 14 fonti
Moderna entwickelt Impfstoff gegen Ebola-Variante
Der US-Pharmakonzern will mit Unterstützung der internationalen Impfallianz CEPI einen Impfstoff gegen das Bundibugyo-Ebolavirus herstellen. Diese Ebola-Variante verbreitet sich gerade in Afrika.© SZ - Rechte am Artikel können Sie hier erwerben.Lesen Sie mehr zum ThemaVideo
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
independent.co.uk
Moderna receives $50 million to develop Ebola vaccine as number of cases surge
This initiative is crucial as health authorities worldwide race to identify medical options and contain the outbreak, which has seen over 900 suspected cases and more than 220…
- ·
it.euronews.com
Autorità sanitaria accelera tre vaccini anti Ebola in piena diffusione
L’ente globale per la salute CEPI sta accelerando lo sviluppo di tre vaccini sperimentali contro il ceppo Bundibugyo dell’Ebola, mentre il focolaio in Africa centrale continua a…
- ·
euronews.com
Health body fast-tracks three Ebola vaccines as virus continues spread
Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.
- ·
Autorità sanitaria accelera tre vaccini anti Ebola
L’ente globale per la salute CEPI sta accelerando lo sviluppo di vaccini sperimentali contro il ceppo Bundibugyo dell’Ebola. Il focolaio in Africa centrale continua a propagarsi
- ·
qz.com
Moderna partners with CEPI on Bundibugyo Ebola vaccine
CEPI is committing up to $50 million to support Moderna's vaccine candidate for the strain with no approved shot
- ·
koreatimes.co.kr
Moderna and other groups get $60 million to develop Ebola vaccine - The Korea Times
Global health organisation CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebo...
- ·
g1.globo.com
Vacina contra ebola: Moderna desenvolve imunizante para cepa rara | G1
Parceria entre Moderna e CEPI foca em vacina contra a cepa Bundibugyo do ebola, enquanto a OMS prioriza imunizantes experimentais para conter surto no Congo.
- ·
oglobo.globo.com
Moderna faz parceria com coalizão global de saúde para desenvolver vacina contra o Ebola Bundibugyo
Doença já registrou cerca de 900 casos suspeitos e mais de 220 mortes suspeitas
- ·
sueddeutsche.de
Moderna entwickelt Impfstoff gegen Ebola-Variante
Der US-Pharmakonzern will mit Unterstützung der internationalen Impfallianz CEPI einen Impfstoff gegen das Bundibugyo-Ebolavirus herstellen. Diese Ebola-Variante verbreitet sich…
- ·
arabnews.com
Moderna and other groups get $60m to develop Ebola vaccine
BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the…
- ·
arstechnica.com
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.
- ·
thejakartapost.com
Moderna and other groups get $60 million to develop Ebola vaccine - Middle East and Africa - The Jakarta Post
The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.
- ·
nation.africa
Scientists target human trials for new Ebola vaccine 'within months'
This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.
- ·
spiegel.de
Internationale Geldgeber investieren Millionen in Ebolaimpfstoffe
Die Zahl der Ebolainfizierten in Zentralafrika wächst. Im Kampf gegen die tödliche Krankheit bekommen Firmen und Forscher nun Finanzhilfen, ein großer Betrag geht an den…
- ·
tagesschau.de
So weit ist die Forschung zu Ebola-Impfstoffen
In der Demokratischen Republik Kongo und in Uganda breitet sich das Ebola-Virus weiter aus. Genau genommen: der seltene Bundibugyo-Stamm. Dagegen gibt es bisher weder Impfstoffe…